| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital London W12 ONN
Department of Histopathology and Cytopathology (J.K.M.), York District Hospital York YO3 7HE, United Kingdom
Address all correspondence and requests for reprints to: Professor S. R. Bloom, Department of Medicine, Francis Fraser Laboratory, 2nd Floor, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom.
The presence of immunoreactive (IR) endothelin, endothelin mRNA, and endothelin receptors in human brain and pituitary gland has been studied by RIA, Northern blot hybridization, and receptor assay. IR endothelin was detected in all five brain regions examined (cerebral cortex, cerebellum, brain stem, basal ganglia, and hypothalamus) (6–10 fmol/g wet wt) and spinal cord (22 ± 6 fmol/g wet wt, n = 7, mean ± SEM). Higher concentrations of IR endothelin were found in the pituitary gland (147 ± 30 fmol/g wet wt). Fast protein liquid chromatographic analysis of the IR endothelin in pituitary gland showed a large IR peak in the position of endothelin-3 and a smaller peak in the position of endothelin-1, whereas IR endothelin in the hypothalamus and brain stem was mainly endothelin-1. Endothelin messenger RNA was detected by Northern blot hybridization in the pituitary but not in hypothalamus. The receptor assay showed that 125I-endothelin-1 binding sites were present in large numbers in all five brain regions but were much less abundant in the pituitary gland. Binding capacity and dissociation constant were 5052 ± 740 fmol/mg protein and 0.045 ± 0.007 nM in brain stem and 963 ± 181 fmol/mg protein and 0.034 ± 0.009 nM in hypothalamus. In the pituitary gland, there were two classes of binding sites for endothelin with dissociation constants of 0.059 ± 0.002 nM (binding capacity = 418 ± 63 fmol/mg protein) and 0.652 ± 0.103 nM (binding capacity = 1717 ± 200 fmol/mg protein). Endothelin-1, -2 and -3 were almost equipotent in displacing the binding (IC50
0.04 nM). These findings are in accord with the possibility that endothelin acts as a neurotransmitter, neuromodulator or neurohormone in man.
Received June 14, 1990.
This article has been cited by other articles:
![]() |
C.-H. Chu, J.-K. Lee, H.-M. Keng, M.-J. Chuang, C.-C. Lu, M.-C. Wang, C.-C. Sun, M.-C. Wei, and H.-C. Lam Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Experimental Biology and Medicine, June 1, 2006; 231(6): 1040 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Rossi and H. Chen Aminopropionic Acid receptors in paraventricular nucleus mediate pressor and vasopressin responses to endothelin-1 in subfornical organ. Experimental Biology and Medicine, June 1, 2006; 231(6): 1075 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Rossi and W. H. Beierwaltes Nitric oxide modulation of ETB receptor-induced vasopressin release by rat and mouse hypothalamo-neurohypophyseal explants Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1208 - R1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Rossi Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E535 - E541. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bychkov, J. Glowinski, and C. Giaume Sequential and opposite regulation of two outward K+ currents by ET-1 in cultured striatal astrocytes Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1373 - C1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsuo, S.-i. Mihara, M. Ninomiya, and M. Fujimoto Protective Effect of Endothelin Type A Receptor Antagonist on Brain Edema and Injury After Transient Middle Cerebral Artery Occlusion in Rats Stroke, September 1, 2001; 32(9): 2143 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Udono, K. Takahashi, M. Nakayama, A. Yoshinoya, K. Totsune, O. Murakami, Y. K. Durlu, M. Tamai, and S. Shibahara Induction of Adrenomedullin by Hypoxia in Cultured Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1080 - 1086. [Abstract] [Full Text] |
||||
![]() |
N. F. Rossi and H. Chen PVN lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E349 - E356. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kurihara, H. Kurihara, H. Morita, W.-H. Cao, G.-Y. Ling, M. Kumada, S. Kimura, R. Nagai, Y. Yazaki, and T. Kuwaki Role of endothelin-1 in stress response in the central nervous system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R515 - R521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maggi, T. Barni, G. Fantoni, R. Mancina, C. Pupilli, M. Luconi, C. Crescioli, M. Serio, and G. B. Vannelli Expression and Biological Effects of Endothelin-1 in Human Gonadotropin-Releasing Hormone-Secreting Neurons J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1658 - 1665. [Abstract] [Full Text] |
||||
![]() |
F. Blomstrand, C. Giaume, E. Hansson, and L. Ronnback Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca2+ signaling Am J Physiol Cell Physiol, October 1, 1999; 277(4): C616 - C627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Evans Modulation of Gonadotropin Levels by Peptides Acting at the Anterior Pituitary Gland Endocr. Rev., February 1, 1999; 20(1): 46 - 67. [Abstract] [Full Text] |
||||
![]() |
F.M. Hofman, P. Chen, R. Jeyaseelan, F. Incardona, M. Fisher, and R. Zidovetzki Endothelin-1 Induces Production of the Neutrophil Chemotactic Factor Interleukin-8 by Human Brain-Derived Endothelial Cells Blood, November 1, 1998; 92(9): 3064 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kanyicska, M. E. Freeman, and S. E. Dryer Endothelin Activates Large-Conductance K+ Channels in Rat Lactotrophs: Reversal by Long-Term Exposure to Dopamine Agonist Endocrinology, August 1, 1997; 138(8): 3141 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |